Sinovac launches Phase 3 trial for COVID-19 vaccine in Indonesia, reports Phase 2 details

China’s Sinovac Biotech Ltd launched a late-stage human trial on Tuesday that will involve as many as 1,620 patients in Indonesia for a COVID-19 vaccine candidate...